Digoxin Use to Control Ventricular Rate in Patients with Atrial Fibrillation and Heart Failure Is Not Associated with Increased Mortality
Introduction. Digoxin is used to control ventricular rate in atrial fibrillation (AF). There is conflicting evidence regarding safety of digoxin. We aimed to evaluate the risk of mortality with digoxin use in patients with AF using meta-analyses. Methods. PubMed was searched for studies comparing ou...
Saved in:
Main Authors: | Surbhi Chamaria, Anand M. Desai, Pratap C. Reddy, Brian Olshansky, Paari Dominic |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2015/314041 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monitoring the complexity of ventricular response in atrial fibrillation
by: H. Käsmacher, et al.
Published: (2000-01-01) -
Meta-Analysis of Atrial Fibrillation Ablation in Patients with Systolic Heart Failure
by: Mohammed Ruzieh, et al.
Published: (2019-01-01) -
Influence of catheter ablation for atrial fibrillation on atrial and ventricular functional mitral regurgitation
by: Masaharu Masuda, et al.
Published: (2022-06-01) -
Combined Nonlinear Analysis of Atrial and Ventricular Series for Automated Screening of Atrial Fibrillation
by: Juan Ródenas, et al.
Published: (2017-01-01) -
Patients with chronic heart failure and predominant left atrial versus left ventricular myopathy
by: Xuanyi Jin, et al.
Published: (2025-02-01)